At the top 36 mg dose, average weight loss was about 11.2% against 2.1% on placebo
Glucagon receptor activation is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis) though these effects remain under investigation in humans and should not be taken as established clinical outcomes
The move is expected to cut prices by roughly half, broaden access, and spark intense competition in what could become one of Indias fastest-growing therapy segments
Pharmacokinetic Profile Route of Administration SC Dosing Frequency Once weekly Half-Life 6 days Formulation & Handling Reconstitute in sterile water or PBS (pH ~7.4) for in vivo/in vitro use Store at 20C in aliquots to prevent freeze-thaw degradation Shelf-stable for 12 months under recommended storage condition Clinical Trial Activity References Quality & Purity This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to 99% purity by HPLC with identity confirmed by mass spectrometry
Your body natural set point mechanisms push you toward weight regain
This occurs because semaglutide slows gastric emptying as part of its mechanism of action, which can lead to harder, less frequent stools
